Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Nov:32 Suppl 2:224-31.
doi: 10.1007/s00292-011-1513-4.

[Precursor lesions of pancreatobiliary cancer]

[Article in German]
Affiliations
Review

[Precursor lesions of pancreatobiliary cancer]

[Article in German]
B Sipos et al. Pathologe. 2011 Nov.

Abstract

Precursor lesions of pancreatobiliary cancer can be divided into cystic and flat lesions. Mucinous cystic neoplasm and intraductal papillary mucinous neoplasm (IPMN) comprise the cystic precursors in the pancreas, while intraductal papillary neoplasm (IPN) represents their counterpart in the bile duct system. There is an adenoma-carcinoma sequence in the cystic precursors arising from four different types of epithelia: pancreatobiliary, oncocytic, intestinal and gastric. These subtypes of IPMN/IPN are morphologically and immunohistochemically well characterised and show clinical and prognostic relevance: the gastric subtype is associated with the best prognosis, followed by the oncocytic and intestinal subtypes, while the pancreatobiliary subtype is characterized by adverse clinical behaviour. Pancreatic intraepithelial neoplasia (PanIN) and biliary intraepithelial neoplasia (BilIN) represent the flat precursors. PanIN are morphologically and biologically well defined. PanIN with lobulocentric atrophy has recently been described as a putative precursor of pancreatic cancer. Despite well defined morphological features in BilIN, the molecular alterations seen during early tumor progression in the biliary tract are poorly understood.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Histopathology. 2009 Aug;55(2):218-29 - PubMed
    1. Am J Surg Pathol. 2001 May;25(5):579-86 - PubMed
    1. Gut. 2002 Jun;50(6):861-8 - PubMed
    1. Cancer Res. 2001 Jan 1;61(1):19-22 - PubMed
    1. Am J Surg Pathol. 2004 Jul;28(7):839-48 - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources